GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Scaled Net Operating Assets

Fabino Life Sciences (BOM:543444) Scaled Net Operating Assets : 0.68 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Fabino Life Sciences's operating assets for the quarter that ended in Mar. 2024 was ₹152.9 Mil. Fabino Life Sciences's operating liabilities for the quarter that ended in Mar. 2024 was ₹99.4 Mil. Fabino Life Sciences's Total Assets for the quarter that ended in Sep. 2023 was ₹79.1 Mil. Therefore, Fabino Life Sciences's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.68.

Fabino Life Sciences Scaled Net Operating Assets Historical Data

The historical data trend for Fabino Life Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences Scaled Net Operating Assets Chart

Fabino Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.19 0.43 1.58 0.93 1.07

Fabino Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial 1.58 0.86 1.00 0.85 0.68

Competitive Comparison of Fabino Life Sciences's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Life Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fabino Life Sciences's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Life Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Fabino Life Sciences's Scaled Net Operating Assets falls into.


Fabino Life Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Fabino Life Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2024 )
=(Operating Assets (A: Mar. 2024 )-Operating Liabilities (A: Mar. 2024 ))/Total Assets (A: Mar. 2023 )
=(152.948-99.435)/50.107
=1.07

where

Operating Assets(A: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=153.568 - 0.62
=152.948

Operating Liabilities(A: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=112.126 - 12.691 - 0
=99.435

Fabino Life Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Sep. 2023 )
=(152.948-99.435)/79.114
=0.68

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=153.568 - 0.62
=152.948

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=112.126 - 12.691 - 0
=99.435

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fabino Life Sciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Fabino Life Sciences (BOM:543444) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Scaled Net Operating Assets
Comparable Companies
BOM:531541 BOM:524661 BOM:531686 BOM:524516 BOM:530207 BOM:539680 BOM:531762 BOM:540108 BOM:524322 BOM:524590 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Website
https://www.fabinolife.com
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines